Effect of Dapagliflozin on Total Heart Failure Events in Patients With HFmrEF or HFpEF
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Disclosure statements are available on the authors' profiles:
JAMA Cardiology
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Effect of Dapagliflozin on Total Heart Failure Events in Patients With Heart Failure With Mildly Reduced or Preserved Ejection Fraction: A Prespecified Analysis of the DELIVER Trial
JAMA Cardiol 2023 Apr 26;[EPub Ahead of Print], PS Jhund, BL Claggett, A Talebi, JH Butt, SB Gasparyan, LJ Wei, ZR McCaw, U Wilderäng, O Bengtsson, AS Desai, M Petersson, AM Langkilde, RA de Boer, AF Hernandez, SE Inzucchi, MN Kosiborod, CSP Lam, FA Martinez, SJ Shah, M Vaduganathan, SD Solomon, JJV McMurrayFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.